Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Marker Therapeutics, Inc. - Common Stock
(NQ:
MRKR
)
2.070
-0.120 (-5.48%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Marker Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Marker Therapeutics Stock Drops After Report About Lymphoma Treatment
↗
August 26, 2025
Marker Therapeutics reports strong safety and efficacy data for MT-601 in lymphoma patients, with durable responses and no serious adverse events.
Via
Benzinga
Tuesday's pre-market session: top gainers and losers
↗
August 26, 2025
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
July 17, 2025
Via
Benzinga
Here are the top movers in Thursday's session.
↗
July 17, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
Gapping stocks in Thursday's session
↗
July 17, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings
↗
July 17, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
July 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 14, 2025
Via
Benzinga
Which stocks have an unusual volume on Monday?
↗
March 10, 2025
Which stocks have an unusual volume on Monday?
Via
Chartmill
This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
March 05, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 05, 2024
Via
Benzinga
MRKR Stock Earnings: Marker Therapeutics Beats EPS for Q2 2024
↗
August 14, 2024
MRKR stock results show that Marker Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
MRKR Stock Earnings: Marker Therapeutics Reported Results for Q4 2023
↗
June 28, 2024
Marker Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 05, 2024
Via
Benzinga
MRKR Stock Earnings: Marker Therapeutics Reported Results for Q1 2024
↗
May 15, 2024
Marker Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization
↗
January 08, 2024
Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its multi-tumor associated antigen (multiTAA)-specific T cell product...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
December 29, 2023
Via
Benzinga
Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 12/11
December 11, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Intraday Session
↗
December 11, 2023
Via
Benzinga
Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?
↗
September 11, 2023
Marker Therapeutics Inc (NASDAQ: MRKR) released the preliminary results of the first participant treated with MT-601, its multi-tumor associated antigen (multiTAA)-specific T cell product targeting 6...
Via
Benzinga
Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies
August 17, 2023
Cranford, New Jersey--(Newsfile Corp. - August 17, 2023) - Marker Therapeutics (NASDAQ: MRKR) highlights...
Via
Newsfile
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
August 09, 2023
It's time to start Wednesday with an overview of all the biggest pre-market stock movers traders need to know about this morning!
Via
InvestorPlace
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
September 11, 2023
Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 28, 2023
Via
Benzinga
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
↗
July 31, 2023
Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 24, 2023
Via
Benzinga
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
July 24, 2023
Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest.
Via
Benzinga
Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 7/24
July 24, 2023
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
